PDCD1 and diffuse large B-cell lymphoma: The prevalence of PD-1 expression in DLBCL ranges from 39.5% to 68.6% and is usually increased on tumor-infiltrating T cells (Yamamoto et al., 2008), with higher levels being associated with poorer prognosis (Zhang et al., 2015; Zhang et al., 2016).